The optimal use of contrast agents at high field MRI-Reference-Cited by-同舟云学术

The optimal use of contrast agents at high field MRI

Published:2006-03-01 Issue:6 Volume:16 Page:1280-1287
ISSN:0938-7994
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Trattnig Siegfried,Pinker Kathia,Ba-Ssalamah Ahmed,Nöbauer-Huhmann Iris-Melanie

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00330-006-0154-0.pdf

Reference56 articles.

1. Frayne R, Goodyear BG, Dickhoff P et al (2003) Magnetic resonance imaging at 3.0 Tesla; Challenges and advantages in clinical neuroimaging. Invest Radiol 38:385–402

2. Schild H (2005) Klinische Hochfeld-MRT. Fortschr Röntgenstr 177:621–631

3. Bernstein MA, Huston J, Lin C et al (2001) High-resolution intracranial and cervical MRA at 3.0 T: technical considerations and initial experience. Magn Reson Med 46:955–962

4. Thulborn KR (1999) Clinical rationale for very high field (3.0 T) functional magnetic resonance imaging. Top Magn Reson Imag 10:37–50

5. Gonen O, Gruber S, Li BS et al (2001) Multivoxel 3D proton spectroscopy in the brain at 1.5 T versus 3.0 T: signal-to-noise ratio and resolution comparison. AJNR 22:1727–1731

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The feasibility of half-dose contrast-enhanced scanning of brain tumours at 5.0 T: a preliminary study;BMC Medical Imaging;2024-04-13

2. The Feasibility of Half-Dose Contrast-Enhanced Scanning of Brain Tumours at 5.0 T: a preliminary study;2023-07-27

3. Ultra-high field brain perfusion MRI;Advances in Magnetic Resonance Technology and Applications;2023

4. Gadolinium‐containing carbon nanomaterials for magnetic resonance imaging: Trends and challenges;Journal of Cellular and Molecular Medicine;2020-03-10

5. Recognition of Brain Metastases Using Gadolinium-Enhanced SWI MRI: Proof-of-Concept Study;Frontiers in Neurology;2020-02-11